“We see great potential for mRNA technology to address a broader range of diseases”

What big plans are in store to enhance the global production of mRNA vaccines in the future? As part of our long-term g...

August 4, 2021 | Wednesday | Opinion
“Keep investing in expanding manufacturing capacity is our commitment to customers”

What are the new initiatives being planned for the APAC market? Are there any launches or announcements in the pipeline ...

August 3, 2021 | Tuesday | Opinion
"We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions"

Can you tell us about the major product releases of STARLIMS since 2020?    It's the result of regular colla...

July 1, 2021 | Thursday | Opinion
For the automation portfolio, we see a strong and growing demand for application-related solutions : Dr Peter Fruhstorfer

In the fiscal year 2020, Eppendorf AG succeeded in posting record revenue of €967.2 million as compared to ...

June 1, 2021 | Tuesday | Opinion
"We've unveiled many novel analytical workflows which can be used in developing vaccines"

With a focus on extending the company’s leadership in quantitative LC-MS, and oversee the launch of innovative tec...

May 10, 2021 | Monday | Opinion
We consider the APA and China markets as highly attractive, fast-growing and very innovative : Eva van Pelt

  1.What have been your key contributions within the organization towards fighting covid-19? The current challeng...

February 28, 2021 | Sunday | Influencers
“We are planning to launch a new bioprocess controller in Q1 2021”

Their applications are diverse, and the products can be found in pharmaceutical, chemical, and nutrition industries. Wit...

January 4, 2021 | Monday | Opinion